The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis

Background Elevated neutrophil count is associated with poor prognosis and increased mortality in many conditions. Neutrophil to lymphocyte ratio (NLR) has emerged as a marker of inflammation in neoplastic and cardiovascular disorders. Herein, we investigated utility of this simple tool in rheumatoi...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical laboratory analysis Vol. 30; no. 5; pp. 597 - 601
Main Authors Mercan, Ridvan, Bitik, Berivan, Tufan, Abdurrahman, Bozbulut, Utku Burak, Atas, Nuh, Ozturk, Mehmet Akif, Haznedaroglu, Seminur, Goker, Berna
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.09.2016
John Wiley & Sons, Inc
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Elevated neutrophil count is associated with poor prognosis and increased mortality in many conditions. Neutrophil to lymphocyte ratio (NLR) has emerged as a marker of inflammation in neoplastic and cardiovascular disorders. Herein, we investigated utility of this simple tool in rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Methods The study consisted of 136 RA and 140 AS patients, along with 117 healthy control subjects. RA and AS activities were determined with Disease Activity Score (DAS) and Bath Ankylosing Spondylitis Disease Activity indices (BASDAI), respectively. The association between NLR and disease activity was analyzed. Results Erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP), and neutrophil counts were significantly higher in RA and AS patients compared to healthy controls. Similarly, NLR was higher compared to control subjects, both in RA (2.53 ± 1.4 vs. 2.16 ± 1.0, P = 0.019) and AS (2.43 ± 1.4 vs. 2.16 ± 1.0, P = 0.077). NLR correlated well with ESR and CRP, both in RA and AS. Moreover, NLR increased across worsening DAS28 activity groups (2.1 ± 1.0 in patients with remission, 2.5 ± 1.0 in low–moderate, 3.8 ± 2.5 in high disease activity). However, no association was found between NLR and BASDAI. Conclusion NLR is a cheap and readily available marker for the assessment of disease activity in RA.
Bibliography:ArticleID:JCLA21908
istex:684B946E204F97C5FE98B9421832556D739649FB
ark:/67375/WNG-BMQGVGF9-M
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0887-8013
1098-2825
DOI:10.1002/jcla.21908